MAJOR BLEEDING IN OUTPATIENTS TREATED WITH WARFARIN - INCIDENCE AND PREDICTION BY FACTORS KNOWN AT THE START OF OUTPATIENT THERAPY

被引：2
|
作者：
LANDEFELD, CS
GOLDMAN, L
机构：
[1] UNIV HOSP CLEVELAND,DEPT MED,CLIN ANAL PROJECT,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,BETH ISRAEL HOSP,SCH MED,JOINT DEPT MED,DIV CLIN EPIDEMIOL,BOSTON,MA 02115
来源：
AMERICAN JOURNAL OF MEDICINE | 1989年 / 87卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 152
页数：9
相关论文
共 50 条
  • [1] PREDICTION OF MAJOR BLEEDING IN OUTPATIENTS TAKING WARFARIN
    LANDEFELD, CS
    COOK, EF
    GOLDMAN, L
    CLINICAL RESEARCH, 1987, 35 (03): : A747 - A747
  • [2] Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
    Beyth, RJ
    Quinn, LM
    Landefeld, CS
    AMERICAN JOURNAL OF MEDICINE, 1998, 105 (02): : 91 - 99
  • [3] Risk of major hemorrhage for outpatients treated with warfarin
    Deborah A. McMahan
    David M. Smith
    Mark A. Carey
    Xiao Hua Zhou
    Journal of General Internal Medicine, 1998, 13 : 311 - 316
  • [4] Risk of major hemorrhage for outpatients treated with warfarin
    McMahan, DA
    Smith, DM
    Carey, MA
    Zhou, XH
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1998, 13 (05) : 311 - 316
  • [5] Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation
    Suzuki, Shinya
    Yamashita, Takeshi
    Kato, Takeshi
    Fujino, Tadashi
    Sagara, Koichi
    Sawada, Hitoshi
    Aizawa, Tadanori
    Fu, Long-Tai
    CIRCULATION JOURNAL, 2007, 71 (05) : 761 - 765
  • [6] Genetic Risk Factors for Major Bleeding in Patients Treated With Warfarin in a Community Setting
    Roth, J. A.
    Boudreau, D.
    Fujii, M. M.
    Farin, F. M.
    Rettie, A. E.
    Thummel, K. E.
    Veenstra, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (06) : 636 - 643
  • [7] Evaluation of the performance of eight scores for prediction of bleeding risk in Brazilian heart disease outpatients treated with warfarin
    Oliveira, J. A. Q.
    Ribeiro, A. L. P.
    Ribeiro, D. D.
    Nobre Junior, V. A.
    Rocha, M. O. C.
    Martins, M. A. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 621 - 621
  • [8] Incidence, risk factors, and outcomes of warfarin-associated major bleeding in Thai population
    Priksri, Watcharapong
    Rattanavipanon, Wipharak
    Saejear, Wiwat
    Tanyasaensook, Krittika
    Phrommintikul, Arintaya
    Chulavatnatol, Suvatna
    Nathisuwan, Surakit
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (07) : 942 - 950
  • [9] Incidence of Thromboembolic Stroke and of Major Bleeding in Patients With Chronic Kidney Disease Treated With and Without Warfarin
    Aronow, Wilbert S.
    Lai, Hoang M.
    Kalen, Phoenix
    Adapa, Sreedhar
    Patel, Kaushal
    Goel, Arvind
    Vinnakota, Ravi
    Chugh, Savneek
    Garrick, Renee
    CIRCULATION, 2009, 120 (18) : S1130 - S1130
  • [10] BLEEDING IN OUTPATIENTS TREATED WITH WARFARIN - RELATION TO THE PROTHROMBIN TIME AND ORGANIC LESIONS
    LANDEFELD, CS
    ROSENBLATT, MW
    COOK, EF
    GOLDMAN, L
    CLINICAL RESEARCH, 1988, 36 (06): : A874 - A874
12345